<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03141476</url>
  </required_header>
  <id_info>
    <org_study_id>AntibioticsCefuroximePV5153</org_study_id>
    <nct_id>NCT03141476</nct_id>
  </id_info>
  <brief_title>Adequacy of Perioperative Cefuroxime Dosage According to the BMI</brief_title>
  <official_title>Perioperative Cefuroxime in Obese Patients: Dosage According to the BMI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the dosage of perioperative cefuroxime for obese patients. Dosage was
      increased if the BMI was over 30kg/m*m and as well over 50kg/m*m. Drug levels were measured
      in blood and tissue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cefuroxime is an often used antibiotic for surgery antibiotic prophylaxis to avoid surgical
      wound infection. In this study the dosage of cefuroxime was adjusted to the BMI:

      less than 30kg/m*m: 1,5g 31-50kg/m*m: 3,0g more than 50kg/m*m: 4,5g

      Cefuroxime was applicated 30 to 60 minutes before the begin of surgery. Drug Levels in blood
      and fat tissue were measured at skin cut (30-60 minutes after application of Cefuroxime), 45
      minutes after skin cut (75-105 minutes after minutes after application of Cefuroxime) and at
      the end of surgery (up to 150 minutes after application of Cefuroxime) .

      The hypothesis of this study is that adequate drug levels are reached in all groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">December 12, 2017</completion_date>
  <primary_completion_date type="Actual">November 12, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>BMI: &lt;30kg/m*m: 1,5g, 31-50kg/m*m: 3,0g, &gt;50kg/m*m: 4,5g</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum level of Cefuroxime</measure>
    <time_frame>30-60 minutes after application of cefuroxime</time_frame>
    <description>Drug Serum Level at skin cut</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum level of Cefuroxime</measure>
    <time_frame>75-105 minutes after application of cefuroxime</time_frame>
    <description>Drug Serum Level 45 minutes after skin cut</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum level of Cefuroxime</measure>
    <time_frame>up to 150 minutes after application of cefuroxime</time_frame>
    <description>Drug Serum Level at the end of surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tissue level of Cefuroxime</measure>
    <time_frame>30-60 minutes after application of cefuroxime</time_frame>
    <description>Drug Tissue Level at skin cut</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tissue level of Cefuroxime</measure>
    <time_frame>75-105 minutes after application of cefuroxime</time_frame>
    <description>Drug Tissue Level 45 minutes after skin cut</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tissue level of Cefuroxime</measure>
    <time_frame>up to 150 minutes after application of cefuroxime</time_frame>
    <description>Drug Tissue Level at the end of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical site infections</measure>
    <time_frame>Time until hospital discharge, estimated time period: up to two weeks</time_frame>
    <description>Incidence of surgical site infections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Retention period</measure>
    <time_frame>Time until hospital discharge, estimated time period: 5-7 days</time_frame>
    <description>Length of stay in hospital</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Obesity; Drug</condition>
  <arm_group>
    <arm_group_label>Cefuroxime 1,5g</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BMI &lt;30kg/m*m</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cefuroxime 3g</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BMI 30-50kg/m*m</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cefuroxime 4,5g</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BMI &gt;50kg/m*m</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cefuroxime 1,5g</intervention_name>
    <description>Patients with BMI of &lt;30kg/m*m: 1,5 g Cefuroxime</description>
    <arm_group_label>Cefuroxime 1,5g</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cefuroxime 3g</intervention_name>
    <description>Patients with BMI of 30-50kg/m*m: 3g Cefuroxime</description>
    <arm_group_label>Cefuroxime 3g</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cefuroxime 4,5g</intervention_name>
    <description>Patients with BMI of &gt;50kg/m*m: 4,5 g Cefuroxime</description>
    <arm_group_label>Cefuroxime 4,5g</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective laparoscopic Intervention

          -  BMI &lt; 90 kg/m*m

          -  age: 18-85 years

        Exclusion Criteria:

          -  known history of allergy to cefuroxime or other cephalosporines

          -  absent consent skill

          -  elective open surgery

          -  preoperative therapy with antibiotics

          -  patient's denial of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Dr. med. Jakob Mueller</investigator_full_name>
    <investigator_title>Senior Physician</investigator_title>
  </responsible_party>
  <keyword>Surgery</keyword>
  <keyword>Obesity</keyword>
  <keyword>Drug</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>Cefuroxime</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cefuroxime</mesh_term>
    <mesh_term>Cefuroxime axetil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

